Related Experiment Videos
Noneffect of oral urinary copper ascorbic acid on reduction glucose test.
Diabetes Care
|January 1, 1978
Summary
High-dose ascorbic acid (vitamin C) supplementation did not cause false-positive results in the copper reduction glucose test (Clinitest) in nondiabetic men. This challenges previous assumptions about vitamin C interference with glucose detection methods.
Area of Science:
- Clinical Chemistry
- Endocrinology
- Nutritional Science
Background:
- Ascorbic acid (vitamin C) is a known reducing agent.
- Previous studies suggested ascorbic acid causes false-positive results in copper reduction glucose tests.
- This interference was theorized due to ascorbic acid's chemical properties.
Purpose of the Study:
- To investigate whether high oral doses of ascorbic acid cause false-positive results in the copper reduction glucose test.
- To re-evaluate the commonly held belief regarding ascorbic acid interference with glucose detection.
Main Methods:
- 10 healthy nondiabetic men participated in the study.
- Participants ingested daily doses of 4 and 6 grams of ascorbic acid.
- A total of 360 copper reduction glucose tests (Clinitest) were performed.
Main Results:
- No false-positive glucose test results were observed in any of the 360 tests conducted.
- Ingesting high doses of ascorbic acid did not interfere with the copper reduction method for glucose detection.
Conclusions:
- The study found no evidence that high oral intake of ascorbic acid leads to false-positive results in the copper reduction glucose test.
- This challenges the established notion of ascorbic acid interference with this specific glucose testing method.